Pfizer, Inc. (NYSE:PFE) recently made a $20 million milestone payment to Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) based on the US Food and Drug Administration’s (FDA) approval of Pfizer’s new drug application (NDA) for Oxecta. Oxecta (formerly known as Acurox) is approved for the management of acute and chronic moderate to severe pain where the use of [...]